Year: 2020

news_6

Daiichi Sankyo Announces Late-Breaking Phase 1 Dose Expansion Data for Patritumab Deruxtecan in Patients with EGFR-Mutated NSCLC at ESMO 2020

HER3 directed ADC demonstrates clinical activity in patients with EGFR-mutated metastatic or unresectable NSCLC previously treated with a tyrosine kinase...

news_6

CyberLink Releases New Versions of its Director Family of Multimedia Editing Software, adding Spectacular effects, Precision Features and Expansive Stock Library

New AI-powered tools and comprehensive Shutterstock library featuring professional-grade photos, videos and audio empower creators of all skill levels to...

news_6

BeiGene Presents Data at ESMO Virtual Congress 2020 on Phase 3 Trial of Tislelizumab in First-Line Non-Squamous Non-Small Cell Lung Cancer and Phase 2 Trial of Pamiparib in Advanced Ovarian Cancer

CAMBRIDGE, Mass. & BEIJING--(BUSINESS WIRE)--$BGNE #BGNE--BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing...